Kobayashi Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KBYPF research report →
About the company
Headquartered in Osaka, Japan, and established in 1886, Kobayashi Pharmaceutical Co. , Ltd. is a global enterprise specializing in the development, manufacturing, and distribution of a wide array of consumer products.
- CEO
- Yumi Nakagawa
- IPO
- 2015
- Employees
- 3,615
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $2.53B
- P/E
- 135.18
- P/S
- 2.49
- P/B
- 1.99
- EV/EBITDA
- 28.99
- Div Yield
- 1.88%
- Gross Margin
- 51.02%
- Op Margin
- 8.24%
- Net Margin
- 1.84%
- ROE
- 1.46%
- ROIC
- 5.30%
- Revenue
- $165.89B · 0.17%
- Net Income
- $3.66B · -63.65%
- EPS
- $49.19 · -63.68%
- Op Income
- $14.86B
- FCF YoY
- 180.27%
- 52W High
- $37.43
- 52W Low
- $34.05
- 50D MA
- $34.05
- 200D MA
- $34.43
- Beta
- 0.26
- Avg Volume
- 583.292
Get TickerSpark's AI analysis on KBYPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our KBYPF coverage
Recent articles, reports, and earnings notes.
No research on KBYPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KBYPF report →Similar companies
Peers in the same neighborhood.